Immunome Inc. — insider transactions

7 transactions on record · IMNM · CIK 1472012

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
7
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
1
Bought, 3m
$0
Sold, 3m
$5.6M
Median disclosure lag
1.0 d
trade date to filing date
Largest single trade, 24m
$2M
2026-07-06
Director share, 12m
100.0%
of transactions where role is stated
Current run
7 sells
consecutive same-direction transactions
Net 3m flow
-$5.6M
purchases minus sales
Total on record
7

Transactions

7 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-08-122026-08-120Barchas IsaacDirectorOpen market sale11,048$27.25$301.1Kfiling
2026-08-122026-08-102Barchas IsaacDirectorOpen market sale10,125$26.07$264Kfiling
2026-08-122026-08-111Barchas IsaacDirectorOpen market sale62,291$26.23$1.6Mfiling
2026-08-102026-08-073Barchas IsaacDirectorOpen market sale15,248$26.06$397.4Kfiling
2026-08-102026-08-064Barchas IsaacDirectorOpen market sale20,840$26.06$543.1Kfiling
2026-07-072026-07-061Barchas IsaacDirectorOpen market sale83,094$24.11$2Mfiling
2026-07-072026-07-070Barchas IsaacDirectorOpen market sale16,906$24.20$409.1Kfiling

Source: U.S. Securities and Exchange Commission, EDGAR

Immunome Inc. insider transactions — 7 filings on record — investment.com